• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与病毒血症的卓越免疫控制相关的I类主要组织相容性复合体(MHC)所呈递的HIV-1表位具有高度受限的适应性景观。

HIV-1 epitopes presented by MHC class I types associated with superior immune containment of viremia have highly constrained fitness landscapes.

作者信息

Gorin Aleksandr M, Du Yushen, Liu Franklin Y, Zhang Tian-Hao, Ng Hwee L, Hofmann Christian, Cumberland William G, Sun Ren, Yang Otto O

机构信息

Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.

Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.

出版信息

PLoS Pathog. 2017 Aug 7;13(8):e1006541. doi: 10.1371/journal.ppat.1006541. eCollection 2017 Aug.

DOI:10.1371/journal.ppat.1006541
PMID:28787455
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5560751/
Abstract

Certain Major Histocompatibility-I (MHC-I) types are associated with superior immune containment of HIV-1 infection by CD8+ cytotoxic T lymphocytes (CTLs), but the mechanisms mediating this containment are difficult to elucidate in vivo. Here we provide controlled assessments of fitness landscapes and CTL-imposed constraints for immunodominant epitopes presented by two protective (B57 and B27) and one non-protective (A02) MHC-I types. Libraries of HIV-1 with saturation mutagenesis of CTL epitopes are propagated with and without CTL selective pressure to define the fitness landscapes for epitope mutation and escape from CTLs via deep sequencing. Immunodominant B57- and B27- present epitopes are highly limited in options for fit mutations, with most viable variants recognizable by CTLs, whereas an immunodominant A02 epitope-presented is highly permissive for mutation, with many options for CTL evasion without loss of viability. Generally, options for evasion overlap considerably between CTL clones despite highly distinct T cell receptors. Finally, patterns of variant recognition suggest population-wide CTL selection for the A*02-presented epitope. Overall, these findings indicate that these protective MHC-I types yield CTL targeting of highly constrained epitopes, and underscore the importance of blocking public escape pathways for CTL-based interventions against HIV-1.

摘要

某些主要组织相容性复合体-I(MHC-I)类型与CD8 +细胞毒性T淋巴细胞(CTL)对HIV-1感染的卓越免疫控制相关,但介导这种控制的机制在体内难以阐明。在这里,我们对由两种保护性(B57和B27)和一种非保护性(A02)MHC-I类型呈递的免疫显性表位的适应性景观和CTL施加的限制进行了对照评估。通过对CTL表位进行饱和诱变的HIV-1文库在有和没有CTL选择压力的情况下进行繁殖,以通过深度测序确定表位突变和逃避CTL的适应性景观。免疫显性的B57和B27呈递的表位在合适突变的选择上受到高度限制,大多数可行变体可被CTL识别,而免疫显性的A02呈递的表位对突变高度宽容,有许多逃避CTL的选择且不丧失活力。一般来说,尽管T细胞受体高度不同,但CTL克隆之间的逃避选择有相当大的重叠。最后,变体识别模式表明群体范围内CTL对A*02呈递的表位进行选择。总体而言,这些发现表明这些保护性MHC-I类型产生针对高度受限表位的CTL靶向作用,并强调了阻断公共逃逸途径对于基于CTL的HIV-1干预措施的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/0ea202cbac0b/ppat.1006541.g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/f7064cd0ab6c/ppat.1006541.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/5badc5f5ed71/ppat.1006541.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/d7ad25ffea1b/ppat.1006541.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/115dec8db077/ppat.1006541.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/55d59ff9498d/ppat.1006541.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/12d91c8ce7ad/ppat.1006541.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/e5022ff835c5/ppat.1006541.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/23bc112958d7/ppat.1006541.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/d0eb9add02e3/ppat.1006541.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/4fece300b243/ppat.1006541.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/bd20959d68cd/ppat.1006541.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/da56d47cd77f/ppat.1006541.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/0ea202cbac0b/ppat.1006541.g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/f7064cd0ab6c/ppat.1006541.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/5badc5f5ed71/ppat.1006541.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/d7ad25ffea1b/ppat.1006541.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/115dec8db077/ppat.1006541.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/55d59ff9498d/ppat.1006541.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/12d91c8ce7ad/ppat.1006541.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/e5022ff835c5/ppat.1006541.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/23bc112958d7/ppat.1006541.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/d0eb9add02e3/ppat.1006541.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/4fece300b243/ppat.1006541.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/bd20959d68cd/ppat.1006541.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/da56d47cd77f/ppat.1006541.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5560751/0ea202cbac0b/ppat.1006541.g013.jpg

相似文献

1
HIV-1 epitopes presented by MHC class I types associated with superior immune containment of viremia have highly constrained fitness landscapes.与病毒血症的卓越免疫控制相关的I类主要组织相容性复合体(MHC)所呈递的HIV-1表位具有高度受限的适应性景观。
PLoS Pathog. 2017 Aug 7;13(8):e1006541. doi: 10.1371/journal.ppat.1006541. eCollection 2017 Aug.
2
Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes.突变对复制适应性和主要组织相容性复合体 I 结合亲和力的影响是导致 HIV-1 Gag 表位逃避细胞毒性 T 淋巴细胞的决定因素之一。
mBio. 2017 Nov 28;8(6):e01050-17. doi: 10.1128/mBio.01050-17.
3
Variable processing and cross-presentation of HIV by dendritic cells and macrophages shapes CTL immunodominance and immune escape.树突状细胞和巨噬细胞对HIV的可变处理和交叉呈递塑造了CTL免疫显性和免疫逃逸。
PLoS Pathog. 2015 Mar 17;11(3):e1004725. doi: 10.1371/journal.ppat.1004725. eCollection 2015 Mar.
4
Cross-Reactivity against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones.针对多种 HIV-1 表位的交叉反应性是 HIV-1 特异性细胞毒性 T 淋巴细胞克隆的特征。
J Virol. 2018 Jul 31;92(16). doi: 10.1128/JVI.00617-18. Print 2018 Aug 15.
5
Linking pig-tailed macaque major histocompatibility complex class I haplotypes and cytotoxic T lymphocyte escape mutations in simian immunodeficiency virus infection.将猪尾猕猴主要组织相容性复合体I类单倍型与猿猴免疫缺陷病毒感染中的细胞毒性T淋巴细胞逃逸突变联系起来。
J Virol. 2014 Dec;88(24):14310-25. doi: 10.1128/JVI.02428-14. Epub 2014 Oct 1.
6
Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.细胞毒性T淋巴细胞(CTL)表位的加工与呈递受损是1型人类免疫缺陷病毒感染中CTL免疫压力主要的逃逸机制。
J Virol. 2004 Feb;78(3):1324-32. doi: 10.1128/jvi.78.3.1324-1332.2004.
7
CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.CTL 逃逸通过蛋白酶体破坏 HIV-1 隐匿表位介导。
PLoS Pathog. 2011 May;7(5):e1002049. doi: 10.1371/journal.ppat.1002049. Epub 2011 May 12.
8
Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.尽管免疫显性的、HLA - A*0201限制的1型人类免疫缺陷病毒细胞毒性T淋巴细胞表位的侧翼序列存在多种变异,但仍能对其进行有效加工。
J Virol. 1999 Dec;73(12):10191-8. doi: 10.1128/JVI.73.12.10191-10198.1999.
9
Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus.初次感染期间,HIV-1特异性细胞毒性T淋巴细胞(CTL)施加的抗病毒压力通过CTL逃逸病毒的快速选择得以证明。
Nat Med. 1997 Feb;3(2):205-11. doi: 10.1038/nm0297-205.
10
Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection.在快速进展性感染中,缺乏病毒逃逸且1型人类免疫缺陷病毒特异性细胞毒性T淋巴细胞的体内激活存在缺陷。
J Virol. 1999 Jul;73(7):5509-19. doi: 10.1128/JVI.73.7.5509-5519.1999.

引用本文的文献

1
Antigen-specific and cross-reactive T cells in protection and disease.抗原特异性和交叉反应性 T 细胞在保护和疾病中的作用。
Immunol Rev. 2023 Jul;316(1):120-135. doi: 10.1111/imr.13217. Epub 2023 May 20.
2
Definition of a New HLA B*52-Restricted Rev CTL Epitope Targeted by an HIV-1-Infected Controller.定义一个新的 HLA B*52 限制的 Rev CTL 表位,该表位由 HIV-1 感染者的控制者靶向。
Viruses. 2023 Feb 18;15(2):567. doi: 10.3390/v15020567.
3
How elite controllers and posttreatment controllers inform our search for an HIV-1 cure.精英控制者和治疗后控制者如何帮助我们寻找 HIV-1 治愈方法。

本文引用的文献

1
Increased sequence coverage through combined targeting of variant and conserved epitopes correlates with control of HIV replication.通过联合靶向变异和保守表位来增加序列覆盖度与控制 HIV 复制相关。
J Virol. 2014 Jan;88(2):1354-65. doi: 10.1128/JVI.02361-13. Epub 2013 Nov 13.
2
Extreme genetic fragility of the HIV-1 capsid.HIV-1 衣壳的极端遗传脆弱性。
PLoS Pathog. 2013;9(6):e1003461. doi: 10.1371/journal.ppat.1003461. Epub 2013 Jun 20.
3
Frequent and variable cytotoxic-T-lymphocyte escape-associated fitness costs in the human immunodeficiency virus type 1 subtype B Gag proteins.
J Clin Invest. 2021 Jun 1;131(11). doi: 10.1172/JCI149414.
4
The Emerging Role for CTL Epitope Specificity in HIV Cure Efforts.CTL 表位特异性在 HIV 治愈努力中的新作用。
J Infect Dis. 2021 Feb 15;223(12 Suppl 2):32-37. doi: 10.1093/infdis/jiaa333.
5
CD8 T cells in HIV control, cure and prevention.HIV 控制、治疗和预防中的 CD8 T 细胞。
Nat Rev Immunol. 2020 Aug;20(8):471-482. doi: 10.1038/s41577-020-0274-9. Epub 2020 Feb 12.
6
Immune Control of HIV.HIV的免疫控制
J Life Sci (Westlake Village). 2019 Jun;1(1):4-37.
7
Structural topology defines protective CD8 T cell epitopes in the HIV proteome.结构拓扑定义了 HIV 蛋白组中的保护性 CD8 T 细胞表位。
Science. 2019 May 3;364(6439):480-484. doi: 10.1126/science.aav5095.
8
Immune Evasion of Enteroviruses Under Innate Immune Monitoring.天然免疫监测下肠道病毒的免疫逃逸
Front Microbiol. 2018 Aug 14;9:1866. doi: 10.3389/fmicb.2018.01866. eCollection 2018.
9
Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes.突变对复制适应性和主要组织相容性复合体 I 结合亲和力的影响是导致 HIV-1 Gag 表位逃避细胞毒性 T 淋巴细胞的决定因素之一。
mBio. 2017 Nov 28;8(6):e01050-17. doi: 10.1128/mBio.01050-17.
频繁且多变的与细胞毒性 T 淋巴细胞逃逸相关的人类免疫缺陷病毒 1 型 B 亚型 Gag 蛋白适应性代价。
J Virol. 2013 Apr;87(7):3952-65. doi: 10.1128/JVI.03233-12. Epub 2013 Jan 30.
4
TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection.T 细胞受体克隆型调节人类免疫缺陷病毒 1 感染中 HLA Ⅰ类分子的保护作用。
Nat Immunol. 2012 Jun 10;13(7):691-700. doi: 10.1038/ni.2342.
5
Epitope targeting and viral inoculum are determinants of Nef-mediated immune evasion of HIV-1 from cytotoxic T lymphocytes.表位靶向和病毒接种量是 Nef 介导的 HIV-1 逃避细胞毒性 T 淋巴细胞免疫的决定因素。
Blood. 2012 Jul 5;120(1):100-11. doi: 10.1182/blood-2012-02-409870. Epub 2012 May 21.
6
Definition of the viral targets of protective HIV-1-specific T cell responses.保护性 HIV-1 特异性 T 细胞应答的病毒靶标的定义。
J Transl Med. 2011 Dec 7;9:208. doi: 10.1186/1479-5876-9-208.
7
Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial.疫苗接种对 STEP 试验中突破性 HIV-1 序列的遗传影响。
Nat Med. 2011 Mar;17(3):366-71. doi: 10.1038/nm.2316. Epub 2011 Feb 27.
8
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.HIV-1 控制的主要遗传决定因素影响 HLA Ⅰ类肽的呈递。
Science. 2010 Dec 10;330(6010):1551-7. doi: 10.1126/science.1195271. Epub 2010 Nov 4.
9
Rapid T cell receptor delineation reveals clonal expansion limitation of the magnitude of the HIV-1-specific CD8+ T cell response.快速 T 细胞受体分析揭示了 HIV-1 特异性 CD8+ T 细胞反应的幅度存在克隆扩增限制。
J Immunol. 2010 Nov 15;185(10):5935-42. doi: 10.4049/jimmunol.1002236. Epub 2010 Oct 13.
10
Fine-tuning of T-cell receptor avidity to increase HIV epitope variant recognition by cytotoxic T lymphocytes.微调 T 细胞受体亲和力,增加细胞毒性 T 淋巴细胞对 HIV 表位变体的识别。
AIDS. 2010 Nov 13;24(17):2619-28. doi: 10.1097/QAD.0b013e32833f7b22.